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The aim of the present study was to determine a detailed mapping of neurotensin (NT) in
the human hypothalamus, during the ﬁrst postnatal year using an in vitro quantitative
autoradiography technique and the selective radioligand monoiodo-Tyr3-NT. Ten human
postmortem hypothalami obtained from control neonates and infants (aged from 2 h
to 1 year of postnatal age) were used. The biochemical kinetics of the binding in all
obtained in this study revealed that the binding afﬁnity constants were of high afﬁnity
(in the nanomolar range) and did not differ signiﬁcantly between all cases investigated.
Furthermore, competition experiments show insensitivity to levocabastine and were in
favor of the presence of the high afﬁnity site of NT receptor. Autoradiographic distribution
showed that NT binding sites were widely distributed throughout the rostrocaudal extent
of the hypothalamus. However, the distribution of NT binding sites was not homogenous
and regional variations exist. In general, the highest densities were mainly present in the
anterior hypothalamic level, particularly in the preoptic area. High NT binding site densities
are also present at the mediobasal hypothalamic level, particularly in the paraventricular,
parafornical, and dorsomedial nuclei. At the posterior level, low to very low densities
could be observed in all the mammillary complex subdivisions, as well as the posterior
hypothalamic area. Although this topographical distribution is almost identical during
the postnatal period analyzed, age-related variations exist in discrete structures of the
hypothalamus. The densities were higher in neonates/less aged infants than older infants
in preoptic area (medial and lateral parts). The developmental proﬁle is characterized by a
progressive decrease from the neonate period to 1 year of postnatal age with a tendency
to reach adult levels. On the other hand, the low levels of NT binding sites observed
in posterior hypothalamus did not vary during the ﬁrst postnatal year. They contrast in
that with the very high levels we reported previously in adult. In conclusion, the present
study demonstrates the occurrence of high NT binding sites density in various structures
in many regions in the human neonate/infant hypothalamus, involved in the control of
neuroendocrine and/or neurovegetative functions.
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INTRODUCTION
The brain-gut peptide neurotensin (NT) is a neurotransmitter and
neuromodulator in the central nervous system (CNS), and acts as
a hormone in the gastrointestinal tract (Hermans and Maloteaux,
Abbreviations: AA, anterior hypothalamic area; Ac, anterior commissure; DA,
dorsal hypothalamic area; DBBh, diagonal band of Broca horizontalis; DBBv, diag-
onal band of Broca verticalis; DM, dorsomedial nucleus; F, Fornix; I, infundibular
nucleus; Ic, intercalates nucleus; LH, lateral hypothalamic area; LM, lateral mam-
millary nucleus; LP, lateral preoptic area; Lt, lateral tuberal nucleus; MM, medial
mammillary nucleus; MP, medial preoptic area; Mt, medial tuberal nucleus; Oc,
optic chiasma; Ot, optic tract; Ovl, organum vasculosum of amina terminalis; PA,
posterior hypothalamic area; Pe, periventricular nucleus; Pf, parafornical nucleus;
PM, paramammillary nucleus; Pva, paraventricular nucleus, anterior part; Pvp,
paraventricular nucleus, posterior part; Sb, Subthalamic nucleus; Sc, suprachia-
matic nucleus; Sh, septohypothalamic nucleus; SM, supramammillary nucleus; So,
Supraoptic nucleus; St, Septothalamic nucleus; TCA, tubero cinereum area; Tm,
tuberomammillary nucleus; Vm, ventromedial nucleus; Z, zona incerta.
1998). Previous studies have shown that NT has a role, in both
central and peripheral nervous systems. NT-producing neurons
and their projections are widely distributed in the CNS, which
explains the wide range of effects of this peptide (for review see
Rostène andAlexander,1997). Theneuropeptide acts via three rec-
ognized receptors: NT1, NT 2, and NT3 (Vita et al., 1993; Mazella
et al., 1996; Martin et al., 2003; Dicou et al., 2004). NT1 and NT2,
are seven transmembrane domain G protein-coupled receptors,
whereas NT3 has a single transmembrane domain sorting recep-
tor that is predominantly associated with vesicular organelles and
shares 100% homology with gp95/sortilin (Vincent et al., 1999).
From a neuroendocrine/ endocrine perspective, the neuropeptide
and its receptors aremainly located in neuronal synaptic vesicles of
hypothalamus (Rostène and Alexander, 1997), in adenohypoph-
ysis cells (Reyes et al., 2008) and in neuroendocrine cells of the
small bowel where they are involved in enteric digestive processes,
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gut motility and intestinal inﬂammatory mechanisms (for review
see Evers, 2006). Previous studies have shown the role of the
peptide in the regulation of the hypothalamo–pituitary–adrenal
gland axis (Geisler et al., 2006). The hypothalamic region is of
particular interest in the study of neuroendocrine regulation and
related endocrine and autonomic disorders due to its role in the
control of hormonal release, funneling converging inputs from
widely distributed vegetative/autonomic regions. Thus, intrac-
erebroventricular or local NT injections in hypothalamus have
been associated with dramatic alterations of the plasma levels of
most anterior pituitary hormones (Alexander and Leeman, 1992;
Vijayan et al., 1994; Rostène and Alexander, 1997; Sicard et al.,
2005). Of interest, the hypothalamus, as reported in laboratory
animals and human is especially enriched in endogenous pep-
tide and NT receptors (Sarrieau et al., 1985; Kanba et al., 1986;
Mai et al., 1987; Sakamoto et al., 1987; Rostène and Alexan-
der, 1997; Najimi et al., 2014). The human hypothalamus is
not completely mature at birth and its maturation continues
during the postnatal period with relation to the maturation of
peptidergic factors regulating pituitary function (Swaab, 1995).
Transient nature of hormone levels seems to prevail for most
of the ﬁrst postnatal life. The stabilization of their rates and
their hypothalamic regulatory systems is observed well after this
period (Donovan, 1980) whichmakes postnatal period highly sen-
sitive to structural or neurochemical alterations. These changes
could perturb not only neuroendocrine circuits sub-serving the
anterior pituitary, but indirectly disrupt widespread hypothala-
mic autonomic functions as well. Indeed, previous studies have
shown that events on early life may have long-term effects on
physiology (Contreras et al., 2013). Dysregulation of NT neuro-
modulation in many brain systems notably during development
has been hypothesized to be involved in the pathogenesis of sev-
eral insults. Changes in levels of NT and its cognate receptors
have been reported in victims of sudden infant death syndrome
(SIDS; Chigr et al., 1992; Coquerel et al., 1992). The relevance
of the neurotensinergic system activity in the correct develop-
ment and function of the human brain seems to be of great
importance.
Developmental aspects of neurotensinergic system in human
hypothalamic–pituitary complex are scare and concerned partic-
ularly the endogenous NT in developing human hypothalamus
(Sakamoto et al., 1987) and pituitary (Reyes et al., 2008). Develop-
mental principles in NT and NT receptors have been extensively
reported in laboratory animals notably in murine brain (Palacios
et al., 1988; Sato et al., 1991, 1992; Lépée-Lorgeoux et al., 2000).
This relevant literature about the neuroanatomy of central NT and
its receptors indicate the presence of different developmental pro-
ﬁles. Moreover, it has been suggested that NT could promote and
sustain survival, and be involved in neuronal migration pattern
and synapse formation (O’Leary and Koester, 1993). In addi-
tion, NT has been shown to promote dendrite elongation and
dendritic spine maturation (Gandou et al., 2010). Finally, stud-
ies in non-neuronal cells have shown that NT exerts mitogenic
and trophic effects in normal and cancer cells in liver, pancreas,
lung, and prostate (Hasegawa et al., 1994; Sehgal et al., 1994).
Although well studied in animals, the developmental character-
istics of NT receptors have been poorly investigated in humans
and no investigations have concerned the hypothalamus. As far
as NT receptors are known to be important in the function of
the neuropeptide, only few studies have speciﬁcally examined
NT receptor development in human brain (the whole hemi-
sphere: Zsürger et al., 1992 and medulla oblongata: Mailleux
et al., 1990; Chigr et al., 1992). In this study, we investigated
the developmental distribution of NT binding sites in normal
post mortem human hypothalamus obtained from newborns and
infants.
MATERIALS AND METHODS
SOURCE AND PREPARATION OF HUMAN TISSUES
We studied NT binding sites in the hypothalami of ten neonates
and infants, autopsied at the Edouard Herriot and Lyon Sud
Hospitals (Lyon, France) in accordance with written consent
from the next of kin and local ethical approval (Ethics Com-
mittee of the two French laboratories). None of these subjects
died as a result of neurologic, neuroendocrine, or endocrine
disease (Table 1) and no pathological lesions were observed
after macroscopic and microscopic examination of the brains.
Ante mortem variables as age and sex were also summarized in
Table 1. Furthermore, available information relating to tissue
donor ante-mortem variables does not indicate the presence of
agonal state or the presence of speciﬁc medication. At autopsy,
the brains were removed from the cranium and the hypothalami
were dissected out at 4◦C by taking the parallel plane join-
ing the optic chiasma and the anterior commissure as frontal
plane and the caudal plane just behind the mammillary complex.
The hypothalamus samples were immediately frozen at −80◦C
and stored at the same temperature until mounted on cryostat
chucks. The frozen hypothalami were then sliced as 20 μm thick
coronal sections at −20◦C (Frigocut 2800, Reichert Jung, Hei-
delberg, Germany). Sections were collected onto chrome alum
gelatin coated slides (Mentzel-Gläser, Braunschweig, Germany)
and stored at −20◦C until use. For the anatomical localization of
the hypothalamic nuclei and areas, sections adjacent to those used
Table 1 | Source of brain tissues.
Cases Sex Age Post-mortem
delay (h)
Cause of death
A F 2 h 14 Pulmonary hypoplasia
B M 35 h 34 Amniotic inhalation with gastric
regurgitation
C M 1 day 10 Oedematic alveolitis with
Refractory hypoplasia
D M 3 days 15 Diaphragmatic hernia
E M 1 month 20 Liver lesions
F M 1 month 5 Enterocolitis
G F 2 months 24 Pulmonary hemorrhage
H F 4 months 24 Kidney medullar invagination
I M 6 months 22 Pneumopathy
J F 1 year 7 Hepatic necrosis
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for autoradiography were stained with cresyl violet. We adopted
conventional nomenclature we used in our previous investigations
(Najimi et al., 2001, 2006, 2014).
IN VITRO QUANTITATIVE AUTORADIOGRAPHY
The slides containing the sections of the hypothalamus were ﬁrst
warmed to room temperature and then incubated at 4◦C for
2 h, with 0.1 nM monoiodo 125I-Tyr-NT (2000 Ci/mmol) in
50 mM Tris-HCl buffer (pH 7.5) containing 5 mM MgCl2, 0.2%
bovine serum albumin and 0.02 mM bacitracin (New England
Nuclear: NEN, Wellesley, MA, USA). Non-speciﬁc binding was
determined as the binding of 125I-NT in the presence of 1 μM
of unlabelled NT1−13. After incubation, the slides were washed
with ice cold buffer four times for 2 min each and rapidly dried
with cold air. Labeled sections and iodinated standards (Amer-
sham, Courtaboeuf Cedex, France) were then apposed to 3H
sensitive Ultroﬁlm (Amersham) in Amersham exposure cassettes.
After 2 weeks exposure in dark conditions at 4◦C, the ﬁlm was
developed in Kodak D19 (Eastman Kodak, Rochester, NY, USA)
for 3 min, dipped in water and ﬁxed with Kodak rapid ﬁxer for
10 min.
Competition experiments were performed by incubating serial
sections from the anterior and mediobasal hypothalamic levels
in the same medium containing graded concentrations of unla-
belled NT (10−12 to 10−6 M). IC50 values were calculated from
inhibition curves as peptide concentrations inhibiting 50% of
monoiodo 125I-Tyr-NT binding. Kinetics (IC50 and KD) analysis
was computed by the method of Parker and Waud (1971).
Densitometric analysis of 125I-NT binding was carried out
according to the methods described previously (Chigr et al., 1992)
using a computer assisted image analysis system (Biocom 2000, les
Ulis, France) and the standards coexposed. Values for total and
non-speciﬁc binding of 125I-NT were obtained for each region by
averaging four to eight readings for each hypothalamic nucleus
and area on an individual autoradiograph.
Statistics
Results were expressed as means ± SEM. The differences of
125I–NT binding site densities between the different age periods
analyzed were evaluated using the analysis of variance (ANOVA)
with 99% signiﬁcant level. When necessary, post hoc tests were
performed and the data were analyzed using the Scheffe’ F test of
the Stat View 512++TM computer program.
RESULTS
We ﬁrstly assessed the binding characteristics of the 125I-NT in the
hypothalami of the cases examined. Computer analysis of binding
isotherms showed that the apparent constant Kd and IC50 are
in the range of 0.88−1.40 nM and 1.96−2.8 Nm, respectively
(Table 2).
AUTORADIOGRAPHIC LOCALIZATION OF 125I-NT BINDING
The autoradiographic labeling was present throughout the rostro-
caudal extent of the hypothalamic region in both neonates and
infants. In all hypothalamic nuclei and areas analyzed, the non-
speciﬁc binding, as determined in the presence of 1 μM NT1−13
was small throughout the concentration range (<10% of total
binding). The distribution of NT binding sites throughout the
Table 2 | Kd values of [125I]-neurotensin 1−13 binding and IC50 values
(Inhibition of specific 125I–NT binding to hypothalamic sections by
unlabeled NT) in different human individuals during the peri- and
postnatal period.
Cases Sex Age PMD Kd (nM) IC50 (nM)
A F 2 h 14 1.40 1.9
B M 35 h 34 0.91 2.6
C M 1 day 10 0.88 2.7
D M 3 days 15 1.45 2.3
E M 1 month 20 0.98 2.8
F M 1 month 5 1.10 2.6
G F 2 months 24 1.20 2.6
H F 4 months 24 0.96 1.9
I M 6 months 22 1.30 2.4
J F 1 year 7 1.10 2.4
Note that neither sex nor age inﬂuence on the values obtained.
human neonate/infant hypothalamus is shown in Figure 1 and
the corresponding drawings are reported in Figure 2. The detailed
mapping has been realized in the three anatomical hypothala-
mic levels, i.e., anterior, mediobasal, and posterior hypothalamus.
Quantiﬁcation of 125I-NT binding site densities in the different
hypothalamic structures is presented in the three histograms rep-
resenting the comparison of NT binding sites density during the
ﬁrst postnatal year in the three hypothalamic levels (Figure 3).
NEONATE
Anterior hypothalamus
The highest densities observed in the anterior hypothalamic level
were present in the diagonal band of Broca and the medial and
lateral preoptic areas (Figures 1A and 3A). Dorsally, low to
moderate autoradiographic labeling was revealed in the septo-
hypothalamic nucleus, whereas the nucleus of the stria terminalis
displayed a dense binding (Figures 1A,B and 3A). At this
level, low binding sites density is present in the anterior, dorsal
and lateral hypothalamic areas as well as the organum vasculo-
sum of lamina terminalis (Figures 1B,C and 3A) whereas the
suprachiasmatic nucleus shows moderate binding site densities
(Figures 1C and 3A) and the autoradiographic labeling was
present throughout the entire structure. At the median level,
low densities of NT binding sites were detected in the periven-
tricular and paraventricular nuclei (Figures 1D and 3A). The
supraoptic nucleus presented a relatively moderate autoradio-
graphic binding, mainly in the ventrolateral part (Figures 1C,D
and 3A). Finally, the fornix column which emerged at this
level as well as the anterior commissure, showed no binding
(Figures 1A–D).
Mediobasal hypothalamus
Generally, the mediobasal hypothalamic level presented relatively
low autoradiographic labeling throughout its whole extent, partic-
ularly in the ventral portion. The infundibular, the ventromedial
and the dorsomedial nuclei displayed equivalent low pattern of
labeling (Figures 1D,E and 3B). In contrast to the anterior
Frontiers in Cellular Neuroscience www.frontiersin.org September 2014 | Volume 8 | Article 251 | 3
Najimi et al. Neurotensin receptors in human infant brain
FIGURE 1 | Autoradiographic images of neurotensin (NT) binding sites
in coronal hypothalamic sections obtained in human neonate.This
ﬁgure represents the most rostral level of the anterior hypothalamus.
A represents the edge of the rostral level at the diagonal band of Broca
(septo-hypothalamic junction), and B represents the beginning of the
hypothalamus senso stricto (preoptic area level). Note that at rostral level,
the binding is higher in the preoptic region, whereas it decreases caudally
at the anterior and dorsal areas (C). D,E represent microphotographs
obtained at the mediobasal level, illustrating the rostrocaudal variations of
NT binding sites. E represents coronal section obtained more caudally,
comprising the junction with the beginning of the posterior hypothalamus.
F illustrates NT binding sites distribution in the posterior level of human
neonate hypothalamus, illustrating the distribution of NT radiolabeling in the
mammillary complex principally and surrounding structures. Scale
bar = 3.5 mm.
hypothalamic level, the mediobasal part of the paraventricular
nucleus as well as in the periventricular nucleus showed moderate
NT binding site densities as (Figures 1E and 3B). The parafor-
nical nucleus also displayed moderate densities. In the posterior
hypothalamic area, NT binding site density was moderate, existing
principally in both its ventral and medial parts. The tuberal nuclei
displayed low to moderate NT binding site density (Figures 1D,E
and 3B), the autoradiographic labeling was homogenous in both
the medial and lateral portions. At the mediobasal hypothala-
mic level, the labeling present in the lateral hypothalamic area
tended to relatively increase but remained in the low density aver-
age. Finally, no signiﬁcant labeling was detected in the median
eminence.
Posterior hypothalamus
In the transition zone between the mediobasal and the posterior
hypothalamus, only low but signiﬁcant NT binding site densities
were detected in the premammillary nucleus and the surrounding
areas (Figures 1E and 3C). At the posterior level, the mammillary
complex presented a diffuse and heterogeneous distribution of NT
binding (Figures 1F and 3C) with a low labeling in all the anatom-
ical components: the lateral mammillary nucleus, the intercalatus
nucleus, and the supramammillary nucleus (Figures 1F and
3C). Dorsally, the posterior hypothalamic area, the subthalam-
icus nucleus and the zona incerta displayed very low densities
(Figures 1F and 3C), while themamillothalamic tract and theVicq
d’Azyr ﬁbers tract surrounding the medial mammillary nucleus
were devoid of binding.
INFANT
Anterior hypothalamus
The pattern of 125I-NT binding was quite similar to that observed
for the neonate with binding sites density being in equivalent
range for all anatomical components except for preoptic region
where the densities were relatively moderate compared to neonate
(20.1 ± 1.8 to 18.7 ± 1.4 in infants aged 1–2 months, vs. 25.1 ± 2.4
to 22.7 ± 2.1 in neonates, p < 0.001; 12.8 ± 2.0 to 13.1 ± 1.1 in
infants aged 4–12 months, vs. 25.1 ± 2.4 to 22.7 ± 2.1 in neonates,
p < 0.001; Figure 3A).
Mediobasal hypothalamus
All the structures analyzed in infant presented similar anatomi-
cal distribution of the autoradiographic labeling and equivalent
densities of NT binding sites (Figure 3B).
Posterior hypothalamus
Similar topography of NT binding sites distribution was also
present for this hypothalamic level in infant and neonate. In all the
structures, the densities were slightly but not signiﬁcantly, higher
in infant than in neonate (Figure 3C).
No signiﬁcant differences related to gender have been seen
in all hypothalamic nuclei and areas in all the postnatal period
investigated.
DISCUSSION
To the best of our knowledge, there is no information concern-
ing the developmental dynamics of NT binding sites in normal
human hypothalamus. We investigated in the present study, the
autoradiographic distribution and quantitation of NT receptors
in hypothalamus of postmortem normal human hypothalamus
during development. This completes our previous study, ana-
lyzing the overall distribution of NT binding sites in the adult
human hypothalamus (Najimi et al., 2014). To date, three NT
receptors with distinct functional and pharmacological proper-
ties have been identiﬁed: NT1, NT2, and nts3 (for review, see
Le et al., 1996; Vincent et al., 1999). NT binds to all three recep-
tors (Vincent et al., 1999). NT has lower afﬁnity for the NT2
receptor compared with the NT1 receptor (Schotte et al., 1986;
Mazella et al., 1996; Vita et al., 1998). In our study, biochemical
characteristics of binding carried out on different hypothalamic
levels, showed that 125I-NT bind to a high-afﬁnity site with a
Kd value varying from 0.88 to 1.40 nM (n = 10). Interestingly,
the afﬁnity of the binding sites labeled for the radiolabeled lig-
and was very close to that reported previously for NT1 receptors
in many species including human (Sarrieau et al., 1985; Szigethy
et al., 1990; Benzing et al., 1992; Chigr et al., 1992; Zsürger
et al., 1992). Furthermore, levocabastine, which has afﬁnity for
the NT2 receptor, did not inhibit speciﬁc binding of 125I-NT
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FIGURE 2 | Corresponding drawings and legends of structures of autoradiograms.
in competition experiments and autoradiographic studies. This
insensitivity was observed for all hypothalamic nuclei and areas
in all cases investigated. This is in favor of the presence of the
high afﬁnity subtype (NT1) in the human hypothalamus and
particularly during the ﬁrst postnatal year. Zsürger et al. (1992)
reported the presence only of the high afﬁnity type during the
ﬁrst postnatal year. The low afﬁnity binding sites were absent
during this period and they were ﬁrst detected in15-month-old
human brain. Thus, from their investigations made on hemi-
spheric membrane preparations containing also the hypothalamic
region, it appears clearly that the high afﬁnity NT1 is the most
abundant receptor subtype in fetuses and early postnatal stages,
whereas later in development, the low afﬁnity NT2 receptor
is successively expressed during deﬁnite periods. Therefore, we
could assume that under our experimental conditions and the
postnatal period we investigated, that the binding sites of NT
we observed; belong to the high afﬁnity NT receptor subtype,
commonly called NT1. In rodent brain, NT1 and NT2 exhibit
markedly different patterns of expression during development.
NT1 expression in most subcortical areas is detectable during
the ﬁrst postnatal week and increases progressively to reach
adult levels by the third week (Palacios et al., 1988; Sato et al.,
1992) whereas NT2 expression is detectable during the second
postnatal week and increases to reach adult levels between the
fourth and eighth weeks after birth (Schotte and Laduron, 1987;
Sarret et al., 1998).
The NT binding sites we identiﬁed in the human hypothala-
mus were detected throughout the entire ﬁrst postnatal period
investigated and did not display different afﬁnities for NT and
analogs. Furthermore, individual kinetic afﬁnities did not vary
signiﬁcantly, arguing for a stability of NT binding sites afﬁnity
during development. Interestingly, kinetics of NT binding, were
equivalent to those we reported in adult hypothalamus (Najimi
et al., 2014) suggesting that they are not age related. Such stabil-
ity during postnatal development for NT binding sites has been
reported previously in other human brain structures (Chigr et al.,
1992; Zsürger et al., 1992).
Autoradiographic studies conducted in the developing
hypothalamus have demonstrated that NT receptors are present
in the entire rostrocaudal extent of the hypothalamic region and
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FIGURE 3 | Age comparison of NT receptor densities in the
human hypothalamus during the peri- and the postnatal periods
in the three hypothalamic levels: anterior (A), mediobasal (B)
and posterior (C). The densities of binding sites are expressed as
mean ± SEM of femtomoles of speciﬁcally bound per mg of
protein (fmole/mg protein). *,**p < 0.001 neonate vs. infant (1–2
months) and neonate vs. infant 4–12 months respectively for medial
preoptic area (MP). *,**p < 0.001 neonate vs. infant (4–12 months)
and infant (1–2 months) vs. infant 4–12 months respectively for
lateral preoptic area (LP).
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were exclusively present in gray matter. However, the labeling of
NT binding sites across the hypothalamic region revealed some-
what several waves of receptors expression during development.
Thus, the comparison of data obtained in preoptic region, at three
age stages studied, from the neonate period to the 1 year post-
natal age, showed gradual and signiﬁcant decrease in NT binding
sites density ( 24,2 ± 2.1 to 22.7 ± 2.1 in the neonate period
vs. 12.8 ± 1.9 to 13.1 ± 1.1 in infant, p < 0.001). This progres-
sive decrease, in density of NT binding sites, starts probably from
the age of 23 weeks post-conceptional (presence of high densi-
ties in a fetus of 23 weeks of conceptional age, equivalent to the
neonatal period, data not shown). This phenomenon continues
throughout the ﬁrst postnatal year and the densities decrease con-
siderably to reach adult levels, but it is difﬁcult with the sample
we used to accurately determine the precise age when densities
reach the level found in adults. Previous radioautographic studies
have also highlighted the presence of more important densities
of NT binding sites during the peri- and postnatal periods, in
different brain structures in humans (Mailleux et al., 1990; Chigr
et al., 1992; Zsürger et al., 1992). These differences in densities
observed during the ﬁrst postnatal period, could not be due to
variation in the afﬁnity. As discussed above, the afﬁnity character-
istics were remarkably stable during the ﬁrst postnatal year. Also,
the altered receptor binding, could not be due to differences in
the postmortem delays (PMD). In accordance of this, previous
studies in human brain with PMD’s up to 42 h (Palacios et al.,
1991) or rat brain up to 48 h (Sadoul et al., 1984) showed no sig-
niﬁcant negative effect of PMD’s on NT binding. Furthermore,
our previous studies in human did not relate any inﬂuence of
this factor on NT receptor density (Sarrieau et al., 1985; Chigr
et al., 1992; Najimi et al., 2014). Finally, the higher PMD of
the sample investigated (34 h, case B) belong to the neonate
group expressing high densities as well as for the lowest PMD
(7 h, case J).
These differences in density observed with age (in the sense
of decreasing density) could be the consequence of neuronal
death involving these binding sites (Stanﬁeld et al., 1982). This
regressive process cell death occurs frequently during develop-
ment in rat CNS is responsible for decreased levels of certain
proteins in neurons after birth (Cowan et al., 1984). It has been
postulated that these occurring changes may also result from elim-
ination of neuronal connections during the fetal and the postnatal
periods, leading to a differential stability of functional synaptic
contacts. The elimination period modifying synaptic intercellu-
lar signals could lead to a repression of gene expression of NT
receptor in hypothalamic neurons. The high expression of NT1
receptor early in development suggests that it may play a spe-
ciﬁc role in the establishment of neuronal circuitry (Boudin et al.,
2000). The physiological signiﬁcance of this transient expres-
sion of NT binding sites during neuronal maturation remains
unknown. It may be suggested that NT acts as a regulatory
peptide during ontogeny. Thus, the presence of NT receptor
before the full establishment of neural networks suggests that
it is involved in the regulation of developmental processes and
maturation of these structures in the human hypothalamus.
The high binding levels observed may be a consequence of the
low levels of NT release and a compensatory up-regulation of
receptors. In accordance of this, previous data report on the
presence of relatively moderate amounts of NT immunoreactivity
in human infant preoptic region, during the ﬁrst postnatal month
(Sakamoto et al., 1987).
As mentioned above and recall here, low binding sites density
is observed during all the ﬁrst postnatal year period in mam-
millary bodies compared to adults (Najimi et al., 2014). This is
similar to that reported previously for somatostatin and benzo-
diazepine binding sites (Najimi et al., 1991, 2001). These results
suggest an incomplete maturation of NT binding sites in these
structures during the ﬁrst postnatal period.We cannot exclude also
that these hypothalamic structures have not yet completed their
neuronal maturation (Kopp et al., 1992). Studies on older ages
should reveal the precise period wherein the densities of bind-
ing sites begin to rise and reach levels observed in adults. It is
also possible that these relatively low densities of NT binding sites
are due to inhibitory control of NT on the endogenous expres-
sion of its correspondent receptor. Indeed, it has been shown
in rat, that a blockade of neurotransmission for 5–9 days after
the birth, with SR 48692 (NT antagonist), increases greatly the
number of NT binding sites (Lépée-Lorgeoux et al., 1999). As
previous studies reporting high and low amounts of endogenous
NT in the human mammillary bodies of infant (Sakamoto et al.,
1987) and adult (Langevin and Emson, 1982), respectively, one
may speculate that endogenous NT levels would be responsible,
at least in part, for the expression of NT binding, in the human
hypothalamus, during peri- and postnatal phases. If in fact the
reduced NT binding represents a physiologically relevant pro-
cess, one plausible explanation would be that NT receptors in the
hypothalamus during the postnatal period are down-regulated.
Alternatively, the observed low levels of these binding sites could
be explained by the fact that the synthesis of high-afﬁnity NT
receptors in fetuses and newborns is delayed in the posterior
hypothalamus as has been reported for somatostatin receptors
(Bologna and Leroux, 2000).
Taken together, it is tempting to postulate that the complex
spatiotemporal pattern of NT binding sites expression in the
developing hypothalamus in human, presumably results, at least
partially, from the action of endogenous NT (Sakamoto et al.,
1987) leading to an up or down regulation of NT receptors, as has
been reported for rat brain (Palacios et al., 1988; Lépée-Lorgeoux
et al., 2000). Nevertheless, and despite the well established mod-
ulatory role of the peptide on NT1 receptors in mature brain in
rat (Azzi et al., 1996), it does not play a major role in establish-
ing their developmental proﬁle during the early postnatal period
(Lépée-Lorgeoux et al., 2000). This could suggest that peptide
release during this period, as well as connection formation, are
probably not sufﬁcient for the regulation of NT1 receptors by the
endogenous ligand. It is therefore possible that other unknown
mechanisms may explain these developmental changes. Thus, the
progressive reduction in NT1 receptors density during the post-
natal period in the human hypothalamus could coincide with
normal maturational events characterized by programmed cell
death of neurons bearing N receptors, or the inﬂuence of hypotha-
lamic inputs on the expression of NT1 receptors. A reduction
in NT binding may simply reﬂect a loss of synaptic connectiv-
ity (Stanﬁeld et al., 1982; Cowan et al., 1984; Zecevic et al., 1989).
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On the contrary, in the posterior hypothalamus, the NT could be
more involved in the maturational process of NT1 receptor. This
could be corroborated by in vitro and in vivo experiments which
have demonstrated a variety of effects of NT in the developmental
processes such as the facilitation of dendritic outgrowth (Gandou
et al., 2010), the regulation of growth factor secretion by astrocytes
(Camby et al., 1996), the modulation of neuron sensitivity to glu-
tamate (Ferraro et al., 2008) as well as important role during the
onset of neuritic ingrowth (Staecker et al., 1996).
The characteristic of postnatal autoradiographic pattern of
125I-NT binding in the human hypothalamus is not unique to the
neurotransmitter/neuromodulator receptor studied to date. Such
a short-lasting expression of a particular receptor has been shown
for vasoactive intestinal peptide (VIP) and benzodiazepine recep-
tors in the hypothalamus during the ﬁrst postnatal year (Najimi
et al., 2001, 2006).
The actions of NT as a regulator of anterior pituitary secretions
and food intake has been well characterized (Rostène and Alexan-
der, 1997; Kalafatakis and Triantafyllou, 2011). Interestingly, the
presence of considerable amounts of the peptide (Sakamoto et al.,
1987) as well as NT binding sites (this study) is in favor of
the direct control or modulation (by ﬁnely tuning feeding reg-
ulation; Brunetti et al., 2005) of these autonomic function in
neonate/infant. This function is highly vital for the survival of the
body during this sensitive period of life. Indeed, neonatal nutri-
tion during critical periods plays a key role in the development of
obesity and related metabolic pathologies such as cardiovascular
disease and type II diabetes (McMillen and Robinson, 2005).
In summary, the results obtained in this study sustain the con-
cept that the NTergic system participates in the development,
differentiation, and maintenance of the human hypothalamus.
As perspectives, the present work should be extended, by inves-
tigating, ﬁrstly the characteristics of NT binding sites during the
other postnatal years (particularly the second postnatal year) to
examine the eventual dynamics in binding site levels notably in
the posterior hypothalamus. Secondly, as the sensitive levocabas-
tine subtype is expressed at the 15th postnatal month in human
brain, it would be very interesting to examine in these postna-
tal ages, if these binding sites subtype are present in the human
hypothalamus.
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